Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M Alper Kursunel"'
Autor:
Ignacio I Wistuba, Mamta Kalra, Linus Backert, Martin Wermke, Edwin R Parra, Jason John Luke, Apostolia M Tsimberidou, Sebastian Bunk, Mohammad B Hossain, Andrea Mayer-Mokler, Arun Satelli, Norbert Hilf, Steffen Walter, Cedrik M Britten, Van K Morris, Tobias A W Holderried, Winfried H Alsdorf, Katrin Wetzko, Borje S Andersson, Sandra Grund-Gröschke, Katrin Aslan, Anantha Marisetty, Swapna Satam, Jens Hukelmann, M Alper Kursunel, Karine Pozo, Andreas Acs, Melissa Baumeister, Claudia Wagner, Oliver Schoor, Ali S Mohamed, Delfi Krishna
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Rationale of the trial Although the use of engineered T cells in cancer immunotherapy has greatly advanced the treatment of hematological malignancies, reaching meaningful clinical responses in the treatment of solid tumors is still challenging. We i
Externí odkaz:
https://doaj.org/article/6a562891133f4ee084b42c34b2d77b3e
Autor:
Beren Karaosmanoglu, M. Alper Kursunel, Duygu Uckan Cetinkaya, Fatma Gumruk, Gunes Esendagli, Sule Unal, Ekim Z. Taskiran
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Diamond Blackfan Anemia (DBA) is an inherited bone marrow (BM) failure syndrome, characterized by a paucity of erythroid differentiation. DBA is mainly caused by the mutations in ribosomal protein genes, hence classified as ribosomopathy. However, in
Externí odkaz:
https://doaj.org/article/bd7cc722831f4f3393567e468ece51db
Autor:
Derya Kızılgöz, Beren Karaosmanoglu, M. Alper Kursunel, Aysegul Uner, Feyza Gul Ozbay, Ekim Z. Taskiran, Gunes Esendagli, Dorina Esendagli, Hamdullah Yanik, Ülkü Yılmaz, Funda Demirag, Ece Tavukcuoglu
Publikováno v:
Cancer Immunology, Immunotherapy
Small cell lung cancer (SCLC) is an aggressive tumor type with early dissemination and distant metastasis capacity. Even though optimal chemotherapy responses are observed initially in many patients, therapy resistance is almost inevitable. According
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63da4ad0c213f7994986c62ed3d007ef
https://aperta.ulakbim.gov.tr/record/239058
https://aperta.ulakbim.gov.tr/record/239058
Autor:
M. Alper Kursunel, Gunes Esendagli
Publikováno v:
EBioMedicine, Vol 23, Iss C, Pp 6-7 (2017)
Externí odkaz:
https://doaj.org/article/1fc06f9abd6a4abe9899fc93d77c9dc9
Autor:
Metin Tülü, M. Alper Kursunel, Sema Çalış, Aysegul Uner, Cisel Aydin, Mustafa Ulvi Gürbüz, Didem Ozkazanc, Kıvılcım Öztürk-Atar, Digdem Yoyen-Ermis, Gunes Esendagli
Publikováno v:
Molecular Pharmaceutics. 15:1526-1533
While reshaping their microenvironment, tumors are also capable of influencing systemic processes including myeloid cell production. Therefore, the tumor-induced myeloid cells, such as myeloid-derived suppressor cells (MDSCs), which are characterized
Autor:
Gunes Esendagli, M. Alper Kursunel
Publikováno v:
Cytokinegrowth factor reviews. 35
Autor:
Gunes Esendagli, M. Alper Kursunel
Publikováno v:
Cytokinegrowth factor reviews. 31
Interferon (IFN)-γ is the uppermost cytokine implicated in anti-tumor immunity. With its cytostatic, pro-apoptotic and immune-provoking effects, IFN-γ plays a central role in the recognition and elimination of transformed cells. Considering well-ch
Autor:
Gunes Esendagli, M. Alper Kursunel
Publikováno v:
EBioMedicine, Vol 23, Iss C, Pp 6-7 (2017)
EBioMedicine
EBioMedicine
Acute myeloid leukemia (AML) is a severe and often fatal systemic malignancy. Malignant cells are capable of escaping host immune surveillance by inactivating cytotoxic lymphoid cells. In this work we discovered a fundamental molecular pathway, which
Autor:
Ahmed Magheli, Waltraut Jekabsons, Sarah Meier, Nafis A. Rahman, Marco Frentsch, Christian Klopf, Xiangdong Li, M. Alper Kursunel, Alberto Sada Japp, Hans Krause, Andreas Thiel, Julia Nora Mälzer
Publikováno v:
Cancer immunology, immunotherapy : CII. 64(11)
The efficacy of immunotherapy in cancer patients is influenced by differences in their immune status. An evaluation of immunocompetence before therapy may help to predict therapeutic success and guide the selection of appropriate regimens. We assesse